Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
JAMA|May 29, 2014
Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trialPeter B Cotton, Valerie Durkalski, Joseph Romagnuolo, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 29, 2023
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 TrialKrista L Lanctôt, Luc Rivet, Shankar Tumati, et al.
International Psychogeriatrics|January 11, 2026
Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) studyKrushnaa Sankhe, Myuri Ruthirakuhan, Ana C Andreazza, et al.
Gastrointestinal Endoscopy|January 30, 2014
Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction?Joseph Romagnuolo, Peter B Cotton, Valerie Durkalski, et al.
Journal of Neurotrauma|January 30, 2021
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical TrialOlga Brawman-Mintzer, X Charlene Tang, Marcel Bizien, et al.
International Psychogeriatrics|April 17, 2023
Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krista L Lanctôt, Clara Chen, Ethan Mah, et al.
International Clinical Psychopharmacology|January 17, 2026
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Madhukar H Trivedi, et al.
Molecular Psychiatry|March 7, 2024
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trialGeorge I Papakostas, Madhukar H Trivedi, Richard C Shelton, et al.
International Clinical Psychopharmacology|May 13, 2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Stefania Chaikali, Clotilde Guidetti, Silvia Ioannou, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders With Treatment Resistant Depression (ASCERTAIN-TRD): Effect of Aripiprazole or Repetitive Transcranial Magnetic Stimulation Augmentation Versus Switching to the Antidepressant Venlafaxine on Quality of LifeClotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.
Pageof 5